Christian Itin
Chairman
Bussiness Management
Kuros Biosciences
Switzerland
Biography
Christian Itin serves as Kuros Chairman of the Board (“Chairman”) since the completion of the merger of Kuros Biosurgery with Cytos Biotechnology in January 2016. Dr. Itin is CEO and Chairman of Autolus Inc., London, UK, since March 2016 and November 2014, respectively. From November 2012 to January 2016, he served as Chairman and CEO of Cytos Biotechnology. Before joining Cytos, Dr. Itin was President and CEO of Micromet Inc., which was acquired in 2012 by Amgen, Inc. Over a period of 13 years, he served in a number of senior management roles at Micromet, becoming CEO in 2004. Dr. Itin received a diploma in biology and a PhD in cell biology from Basel University, Switzerland. In addition, he performed post-doctoral research at the Biocenter of Basel University, Switzerland, and at Stanford University School of Medicine, Stanford, California, USA. Dr. Itin also serves as non-executive director of Kymab Ltd, Cambridge, UK. Christian Itin is a Swiss citizen and resident of Germany.
Research Interest
Bussiness Management
